ArticleBMJ open respiratory research2025

Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial.

Valeria Santibanez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.